{"entity":"johnson-johnson","id":"ent_johnson-johnson","name":"Johnson & Johnson","wikidata":"Q333718","page":"https://asof.is/record/johnson-johnson","summary":"Johnson & Johnson is an U.S. multinational manufacturer of pharmaceuticals and medical devices, headquartered in New Brunswick. Its CEO is Joaquín Duato, since 2022. It reported revenue of $88.82B for the period ended December 29, 2024.","title":"Johnson & Johnson: CEO Joaquín Duato, revenue $88.82B","key_facts":[{"label":"CEO","value":"Joaquín Duato","note":"since 2022","claim":"clm_417259548AAF"},{"label":"Chair","value":"Joaquin Duato","claim":"clm_4B621D47F882"},{"label":"Headquarters","value":"New Brunswick","claim":"clm_5D9D7F332E94"},{"label":"Revenue","value":"$88.82B","recorded":"88,821,000,000 United States dollar","note":"to 2024-12-29","claim":"clm_948A7BE90437"},{"label":"Ticker","value":"JNJ · NYSE","claim":"clm_AC3F2B6AB463"}],"faq":[{"question":"Who is the CEO of Johnson & Johnson?","answer":"Joaquín Duato, since 2022, as the AsOf record states with its sources."},{"question":"Where is Johnson & Johnson headquartered?","answer":"New Brunswick."},{"question":"What is Johnson & Johnson's revenue?","answer":"$88.82B for the period ended December 29, 2024."}],"as_of":"2025-11-08","known_by":null,"since":null,"fact_pages":[{"predicate":"ceo","page":"https://asof.is/record/johnson-johnson/ceo","md":"https://asof.is/record/johnson-johnson/ceo.md","json":"https://asof.is/v1/entities/johnson-johnson/ceo"},{"predicate":"chair","page":"https://asof.is/record/johnson-johnson/chair","md":"https://asof.is/record/johnson-johnson/chair.md","json":"https://asof.is/v1/entities/johnson-johnson/chair"},{"predicate":"headquarters","page":"https://asof.is/record/johnson-johnson/headquarters","md":"https://asof.is/record/johnson-johnson/headquarters.md","json":"https://asof.is/v1/entities/johnson-johnson/headquarters"},{"predicate":"revenue","page":"https://asof.is/record/johnson-johnson/revenue","md":"https://asof.is/record/johnson-johnson/revenue.md","json":"https://asof.is/v1/entities/johnson-johnson/revenue"},{"predicate":"net_income","page":"https://asof.is/record/johnson-johnson/net_income","md":"https://asof.is/record/johnson-johnson/net_income.md","json":"https://asof.is/v1/entities/johnson-johnson/net_income"},{"predicate":"operating_income","page":"https://asof.is/record/johnson-johnson/operating_income","md":"https://asof.is/record/johnson-johnson/operating_income.md","json":"https://asof.is/v1/entities/johnson-johnson/operating_income"},{"predicate":"quarterly_revenue","page":"https://asof.is/record/johnson-johnson/quarterly_revenue","md":"https://asof.is/record/johnson-johnson/quarterly_revenue.md","json":"https://asof.is/v1/entities/johnson-johnson/quarterly_revenue"}],"products":[],"coverage":{"entity":"johnson-johnson","name":"Johnson & Johnson","kind":"organization","sources":[{"source":"wikidata","item":"Q333718","covers":"dated statements whose reference URL is the source: leadership, ownership, names, founding, headquarters; never financial figures"},{"source":"wikidata-products","covers":"products it makes, develops or publishes, as released claims, when the release date cites a reference URL; a rotating scan, a few dozen entities a run"},{"source":"sec","cik":200406,"ticker":"JNJ","covers":"annual and quarterly figures from XBRL, registrant name, tickers and fiscal year end; officer and director changes (8-K Item 5.02) and material events (other 8-K items)"}],"holds":{"claims":435,"open":21,"retracted":0,"first":"1886-01-01","predicates":{"cash_and_equivalents":{"claims":76,"open":1,"kind":"fact"},"quarterly_revenue":{"claims":36,"open":1,"kind":"fact"},"total_equity":{"claims":73,"open":1,"kind":"fact"},"shares_outstanding":{"claims":70,"open":1,"kind":"fact"},"total_assets":{"claims":71,"open":1,"kind":"fact"},"net_income":{"claims":16,"open":1,"kind":"fact"},"cik":{"claims":1,"open":1,"kind":"identifier"},"quarterly_net_income":{"claims":46,"open":1,"kind":"fact"},"operating_income":{"claims":6,"open":1,"kind":"fact"},"quarterly_operating_income":{"claims":15,"open":1,"kind":"fact"},"revenue":{"claims":10,"open":1,"kind":"fact"},"x_username":{"claims":1,"open":1,"kind":"identifier"},"registrant_name":{"claims":2,"open":1,"kind":"fact"},"research_and_development":{"claims":5,"open":1,"kind":"fact"},"fiscal_year_end":{"claims":1,"open":1,"kind":"identifier"},"headquarters":{"claims":1,"open":1,"kind":"fact"},"sic_industry":{"claims":1,"open":1,"kind":"identifier"},"ticker":{"claims":1,"open":1,"kind":"identifier"},"listed_on":{"claims":1,"open":1,"kind":"fact"},"state_of_incorporation":{"claims":1,"open":1,"kind":"identifier"},"website":{"claims":1,"open":1,"kind":"identifier"}}},"freshness":[{"origin":"sec","label":"SEC EDGAR filings: XBRL figures, registry fields, 8-K officer changes and events (sec_ingest.py, sec_officers.py, sec_events.py)","claims":433,"last_added":"2026-11-08","last_checked":"2026-11-08","last_verified":null},{"origin":"wikidata","label":"Wikidata statements that cite a reference URL (wikidata_ingest.py)","claims":2,"last_added":"2026-11-08","last_checked":"2026-11-08","last_verified":null}],"gaps":["ceo: none public; unknown, not absent: a claim is published only once checked against its source","posts: no official feed speaks for it (pipeline/feeds.json primary_for); what it holds comes from Wikidata, filings and other publishers' feeds"],"group":[],"group_complete":true,"rule":"sources: what the pipeline reads for this entity, from its config (pipeline/entities.json, feeds.json, sec_companies.json, huggingface_authors.json). holds: its public claims by predicate; open is held today; kind fact is what entity_state answers by default, event is for timeline. freshness, per ingest (origin): last_added is the day it last put a new claim here (first_seen_at), last_checked the day one was last checked against its source (checked_on), last_verified the day reverify.py last confirmed one against Wikidata (value_json.verified_at). Only checked claims are public, so a fact missing here is unknown, not absent. gaps: what the record does not cover for this entity, so an empty answer is not read as news."},"claims":[{"id":"clm_A4F230EF9BBB","predicate":"cash_and_equivalents","value":"18,231,000,000 United States dollar","valid_from":"2025-09-28","valid_to":"2025-12-28","published":"2025-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cash and equivalents: 18,231,000,000 United States dollar\", as of 2025-09-28 (until 2025-12-28). Claim clm_A4F230EF9BBB, https://asof.is/claim/clm_A4F230EF9BBB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm.","url":"https://asof.is/claim/clm_A4F230EF9BBB","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_9D46DE0A4F23","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-22T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:CashAndCashEquivalentsAtCarryingValue in 10-Q Q3 FY2025, filed 2025-10-22"}},{"id":"clm_417259548AAF","predicate":"ceo","value":"Joaquín Duato","valid_from":"2022-01-03","valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson ceo: Joaquín Duato\", as of 2022-01-03. Claim clm_417259548AAF, https://asof.is/claim/clm_417259548AAF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040622000004/jnj-20220106.htm.","url":"https://asof.is/claim/clm_417259548AAF","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.wikidata.org/wiki/Q333718","tier":"secondary","publisher":"Wikidata","published_at":null},{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040622000004/jnj-20220106.htm","tier":"primary","publisher":null,"published_at":null},{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040621000061/exhibit99.htm","tier":"primary","publisher":null,"published_at":null}],"evidence":{"by":"page-read","on":"2026-11-09","quote":"effective as of January 3, 2022, Joaquin Duato, previously Vice Chairman of the Company’s Executive Committee, assumed the role of Chief Executive Officer (“CEO”) of the Company","url":"https://www.sec.gov/Archives/edgar/data/200406/000020040622000004/jnj-20220106.htm"}},{"id":"clm_4B621D47F882","predicate":"chair","value":"Joaquin Duato","valid_from":"2023-01-01","valid_to":null,"published":"2026-03-11","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson chair: Joaquin Duato\", as of 2023-01-01. Claim clm_4B621D47F882, https://asof.is/claim/clm_4B621D47F882, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040626000016/jnj-20251228.htm.","url":"https://asof.is/claim/clm_4B621D47F882","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000016/jnj-20251228.htm","tier":"primary","publisher":null,"published_at":null},{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000063/jnj-20260309.htm","tier":"primary","publisher":"SEC EDGAR DEF 14A","published_at":"2026-03-11T00:00:00+00:00"}],"evidence":{"by":"page-read","on":"2026-11-09","quote":"Joaquin Duato, 63 Chairman of the Board; Chief Executive Officer Mr. J. Duato became Chairman of the Board of Directors in 2023 subsequent to his appointments as Chief Executive Officer and Director in 2022.","url":"https://www.sec.gov/Archives/edgar/data/200406/000020040626000016/jnj-20251228.htm"}},{"id":"clm_0AE18A6EB213","predicate":"cik","value":"0000200406","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson cik: 0000200406\", undated. Claim clm_0AE18A6EB213, https://asof.is/claim/clm_0AE18A6EB213, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406.","url":"https://asof.is/claim/clm_0AE18A6EB213","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_5254AF4AFDB0","predicate":"fiscal_year_end","value":"01-03","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson fiscal year end: 01-03\", undated. Claim clm_5254AF4AFDB0, https://asof.is/claim/clm_5254AF4AFDB0, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406.","url":"https://asof.is/claim/clm_5254AF4AFDB0","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_5D9D7F332E94","predicate":"headquarters","value":"New Brunswick","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson headquarters: New Brunswick\", undated. Claim clm_5D9D7F332E94, https://asof.is/claim/clm_5D9D7F332E94, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406.","url":"https://asof.is/claim/clm_5D9D7F332E94","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406","tier":"primary","publisher":"SEC EDGAR","published_at":null},{"url":"https://www.wikidata.org/wiki/Q333718","tier":"secondary","publisher":"Wikidata","published_at":null},{"url":"https://www.med-dept.com/resources/ww2-medical-equipment-manufacturers-and-suppliers/","tier":"secondary","publisher":null,"published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_BCF468D9A07B","predicate":"listed_on","value":"NYSE","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson listed on: NYSE\", undated. Claim clm_BCF468D9A07B, https://asof.is/claim/clm_BCF468D9A07B, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406.","url":"https://asof.is/claim/clm_BCF468D9A07B","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_62CFC14840C5","predicate":"net_income","value":"14,066,000,000 United States dollar","valid_from":"2024-12-29","valid_to":"2025-12-28","published":"2025-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson net income: 14,066,000,000 United States dollar\", as of 2024-12-29 (until 2025-12-28). Claim clm_62CFC14840C5, https://asof.is/claim/clm_62CFC14840C5, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/0000200406-25-000038-index.htm.","url":"https://asof.is/claim/clm_62CFC14840C5","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_04E6B87CA267","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/0000200406-25-000038-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-13T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-K FY2024, filed 2025-02-13"}},{"id":"clm_BAB563999E2E","predicate":"operating_income","value":"21,590,000,000 United States dollar","valid_from":"2014-12-28","valid_to":null,"published":"2015-02-24","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson operating income: 21,590,000,000 United States dollar\", as of 2014-12-28. Claim clm_BAB563999E2E, https://asof.is/claim/clm_BAB563999E2E, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040615000004/0000200406-15-000004-index.htm.","url":"https://asof.is/claim/clm_BAB563999E2E","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040615000004/0000200406-15-000004-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2014","published_at":"2015-02-24T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2014, filed 2015-02-24"}},{"id":"clm_4AB4EF856D4C","predicate":"quarterly_net_income","value":"5,152,000,000 United States dollar","valid_from":"2025-09-28","valid_to":"2026-03-29","published":"2025-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly net income: 5,152,000,000 United States dollar\", as of 2025-09-28 (until 2026-03-29). Claim clm_4AB4EF856D4C, https://asof.is/claim/clm_4AB4EF856D4C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm.","url":"https://asof.is/claim/clm_4AB4EF856D4C","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_636E850C3608","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-22T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:NetIncomeLoss in 10-Q Q3 FY2025, filed 2025-10-22"}},{"id":"clm_B42FC6E71EE6","predicate":"quarterly_operating_income","value":"5,827,000,000 United States dollar","valid_from":"2015-03-29","valid_to":null,"published":"2015-05-01","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly operating income: 5,827,000,000 United States dollar\", as of 2015-03-29. Claim clm_B42FC6E71EE6, https://asof.is/claim/clm_B42FC6E71EE6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040615000019/0000200406-15-000019-index.htm.","url":"https://asof.is/claim/clm_B42FC6E71EE6","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040615000019/0000200406-15-000019-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q1 FY2015","published_at":"2015-05-01T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2015, filed 2015-05-01"}},{"id":"clm_729D980FE153","predicate":"quarterly_revenue","value":"23,993,000,000 United States dollar","valid_from":"2025-09-28","valid_to":"2026-03-29","published":"2025-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson quarterly revenue: 23,993,000,000 United States dollar\", as of 2025-09-28 (until 2026-03-29). Claim clm_729D980FE153, https://asof.is/claim/clm_729D980FE153, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm.","url":"https://asof.is/claim/clm_729D980FE153","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_1D62C3B5C845","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-22T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-Q Q3 FY2025, filed 2025-10-22"}},{"id":"clm_3F2BC974D10A","predicate":"registrant_name","value":"JOHNSON & JOHNSON","valid_from":"1996-01-23","valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson registrant name: JOHNSON & JOHNSON\", as of 1996-01-23. Claim clm_3F2BC974D10A, https://asof.is/claim/clm_3F2BC974D10A, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406.","url":"https://asof.is/claim/clm_3F2BC974D10A","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_447FFAF7D0DA","predicate":"research_and_development","value":"1,841,000,000 United States dollar","valid_from":"2024-12-29","valid_to":"2025-12-28","published":"2025-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson research and development: 1,841,000,000 United States dollar\", as of 2024-12-29 (until 2025-12-28). Claim clm_447FFAF7D0DA, https://asof.is/claim/clm_447FFAF7D0DA, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/0000200406-25-000038-index.htm.","url":"https://asof.is/claim/clm_447FFAF7D0DA","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_845673D0E6C8","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/0000200406-25-000038-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-13T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:ResearchAndDevelopmentExpense in 10-K FY2024, filed 2025-02-13"}},{"id":"clm_948A7BE90437","predicate":"revenue","value":"88,821,000,000 United States dollar","valid_from":"2024-12-29","valid_to":"2025-12-28","published":"2025-02-13","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson revenue: 88,821,000,000 United States dollar\", as of 2024-12-29 (until 2025-12-28). Claim clm_948A7BE90437, https://asof.is/claim/clm_948A7BE90437, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/0000200406-25-000038-index.htm.","url":"https://asof.is/claim/clm_948A7BE90437","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_249E6427F083","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000038/0000200406-25-000038-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2024","published_at":"2025-02-13T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax in 10-K FY2024, filed 2025-02-13"}},{"id":"clm_D97FEC131483","predicate":"shares_outstanding","value":"2,409,295,102 shares","valid_from":"2025-10-17","valid_to":"2026-02-06","published":"2025-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson shares outstanding: 2,409,295,102 shares\", as of 2025-10-17 (until 2026-02-06). Claim clm_D97FEC131483, https://asof.is/claim/clm_D97FEC131483, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm.","url":"https://asof.is/claim/clm_D97FEC131483","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_DD98E84FA8C5","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-22T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"dei:EntityCommonStockSharesOutstanding in 10-Q Q3 FY2025, filed 2025-10-22"}},{"id":"clm_94332C756B27","predicate":"sic_industry","value":"Pharmaceutical Preparations (2834)","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson sic industry: Pharmaceutical Preparations (2834)\", undated. Claim clm_94332C756B27, https://asof.is/claim/clm_94332C756B27, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406.","url":"https://asof.is/claim/clm_94332C756B27","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_CF21B28C04B0","predicate":"state_of_incorporation","value":"NJ","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson state of incorporation: NJ\", undated. Claim clm_CF21B28C04B0, https://asof.is/claim/clm_CF21B28C04B0, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406.","url":"https://asof.is/claim/clm_CF21B28C04B0","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_AC3F2B6AB463","predicate":"ticker","value":"JNJ","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson ticker: JNJ\", undated. Claim clm_AC3F2B6AB463, https://asof.is/claim/clm_AC3F2B6AB463, accessed 2026-11-09. Source: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406.","url":"https://asof.is/claim/clm_AC3F2B6AB463","accessed":"2026-11-09"},"confidence":0.95,"status":"valid","assertable":true,"superseded_by":null,"sources":[{"url":"https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000200406","tier":"primary","publisher":"SEC EDGAR","published_at":null}],"evidence":{"by":"sec-filing","on":"2026-11-08"}},{"id":"clm_7E3589121DB9","predicate":"total_assets","value":"192,816,000,000 United States dollar","valid_from":"2025-09-28","valid_to":"2025-12-28","published":"2025-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total assets: 192,816,000,000 United States dollar\", as of 2025-09-28 (until 2025-12-28). Claim clm_7E3589121DB9, https://asof.is/claim/clm_7E3589121DB9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm.","url":"https://asof.is/claim/clm_7E3589121DB9","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_AFEC68E6D52E","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-22T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:Assets in 10-Q Q3 FY2025, filed 2025-10-22"}},{"id":"clm_63969A827BEB","predicate":"total_equity","value":"79,277,000,000 United States dollar","valid_from":"2025-09-28","valid_to":"2025-12-28","published":"2025-10-22","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson total equity: 79,277,000,000 United States dollar\", as of 2025-09-28 (until 2025-12-28). Claim clm_63969A827BEB, https://asof.is/claim/clm_63969A827BEB, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm.","url":"https://asof.is/claim/clm_63969A827BEB","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_BDE73F201969","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/200406/000020040625000209/0000200406-25-000209-index.htm","tier":"primary","publisher":"SEC EDGAR 10-Q Q3 FY2025","published_at":"2025-10-22T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:StockholdersEquity in 10-Q Q3 FY2025, filed 2025-10-22"}},{"id":"clm_E1C3F58B38A0","predicate":"website","value":"https://www.jnj.com","valid_from":null,"undated":true,"valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson website: https://www.jnj.com\", undated. Claim clm_E1C3F58B38A0, https://asof.is/claim/clm_E1C3F58B38A0, accessed 2026-11-09. Source: https://www.wikidata.org/wiki/Q333718.","url":"https://asof.is/claim/clm_E1C3F58B38A0","accessed":"2026-11-09"},"confidence":0.45,"status":"unverified","assertable":false,"why_not":"low_confidence","superseded_by":null,"sources":[{"url":"https://www.wikidata.org/wiki/Q333718","tier":"secondary","publisher":"Wikidata","published_at":null}],"evidence":{"by":"own-site","on":"2026-11-08","quote":"Johnson & Johnson: Changing health for humanity.","url":"https://www.jnj.com"}},{"id":"clm_3B23008B4919","predicate":"x_username","value":"JNJNews","valid_from":"2009-02-09","valid_to":null,"published":null,"recorded":"2026-11-08","citation":{"plain":"AsOf. \"Johnson & Johnson x username: JNJNews\", as of 2009-02-09. Claim clm_3B23008B4919, https://asof.is/claim/clm_3B23008B4919, accessed 2026-11-09. Source: https://www.wikidata.org/wiki/Q333718.","url":"https://asof.is/claim/clm_3B23008B4919","accessed":"2026-11-09"},"confidence":0.6,"status":"unverified","assertable":false,"why_not":"unverified","superseded_by":null,"sources":[{"url":"https://www.wikidata.org/wiki/Q333718","tier":"secondary","publisher":"Wikidata","published_at":null}],"evidence":{"by":"own-site","on":"2026-11-08","quote":"https://twitter.com/JNJNews","url":"https://www.jnj.com"}}],"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{"low_confidence":"Confidence below 0.5, the line the record asserts at.","unverified":"Unverified: one source that is not primary, or a primary source below confidence 0.7. Asserted once a primary source or a second independent domain confirms it."},"checked_by":{"sec-filing":"parsed from the SEC filing","page-read":"its source page states the value and the date","own-site":"the entity's own site names it (a website whose page names the entity, a handle its website links to)"}}}